Epigenetic mechanisms control gene expression without changing the DNA sequence itself. Recent research progress has shown that epigenetic pathways may provide new therapeutic avenues in cancer. It is now apparent that changes in epigenetic control of gene expression in cancer cells, and surrounding cells in the tumor microenvironment, play a fundamental role in driving tumor development, as well as response to chemotherapy and immune treatment. Come to understand epigenetic effector pathways involved in tumor biology and new approaches to target these pathways in cancer treatment.
Objectives
Grasping the relationship between cancer and the immune system is complicated, but it is key to understanding the growing field of immunology and personalized medicine. Gain insight on how you can learn to help the body's immune system control cancer.
Co-Chairs
Benjamin Levy, MD
Assistant Professor, Icahn School of Medicine
Medical Director, Thoracic Oncology Program, Mount Sinai Health Systems
Associate Director, Cancer Clinical Trials Office, Mount Sinai Hospital
Mount Sinai Hospital
New York, NY
Karen Lee, MSN, FNP-BC
Mount Sinai Hospital
New York, NY
Faculty
Laura Brennan FNP-c, AOCNP
Division of Hematology & Oncology
UC Davis Medical Center
Sacramento, CA
Ann Culkin, RN, OCN
Department of Nursing
Office Practice Nurse, Outpatient Thoracic Service
Memorial Sloan Kettering Cancer Center
New York, NY
Alexander E. Drilon, MD
Thoracic Oncology Service
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY
Jonathan Riess, MD, MS
Assistant Professor of Medicine
Division of Hematology Oncology
UC Davis Comprehensive Cancer Center
Sacramento, CA
The development of new therapies aimed at the immune system to control cancer is exploding. It seems as if every day new drugs are being tested and released. Oncology APNs need to understand what these therapies are, how they work, and who should be receiving them. In this session, you’ll get the very latest information on monoclonal antibodies, cancer vaccines, immune checkpoint inhibitors, and more.
An expert panel of world-renowned nurse research scientists will explore the successes and challenges in symptom science. Discover the state of this research priority, including new models from NIH/NINR and implications for future research and practice. Join the discussion and get a glimpse of the future!
Objectives
Analysis of current data reveals a need for information related to care of women with different levels of risk of developing breast cancer. Gain the knowledge you need on breast cancer screening guidelines for women of average risk and learn about identification and medical management of breast cancer screening guidelines for women of high risk.
Sponsored by the Prevention/Early Detection Special Interest Group
*Special interest group sessions are not part of the Congress evaluation. To earn your CNE, fill out the evaluation form given to you upon arrival to the SIG session and follow any directions provided by the session leader. Learn more about SIG Congress sessions.
This continuing nursing education activity was approved by the Oncology Nursing Society, an accredited approver by the American Nurses Credentialing Center’s COA.
